Literature DB >> 26361158

Predictors of Catastrophic Adverse Outcomes in Children With Pulmonary Hypertension Undergoing Cardiac Catheterization: A Multi-Institutional Analysis From the Pediatric Health Information Systems Database.

Michael L O'Byrne1, Andrew C Glatz2, Brian D Hanna3, Russell T Shinohara4, Matthew J Gillespie3, Yoav Dori3, Jonathan J Rome3, Steven M Kawut5.   

Abstract

BACKGROUND: Cardiac catheterization is the standard of care procedure for diagnosis, choice of therapy, and longitudinal follow-up of children and adults with pulmonary hypertension (PH). However, the procedure is invasive and has risks associated with both the procedure and recovery period.
OBJECTIVES: The purpose of this study was to identify risk factors for catastrophic adverse outcomes in children with PH undergoing cardiac catheterization.
METHODS: We studied children and young adults up to 21 years of age with PH undergoing 1 or more cardiac catheterization at centers participating in the Pediatric Health Information Systems database between 2007 and 2012. Using mixed-effects multivariable regression, we assessed the association between pre-specified subject- and procedure-level covariates and the risk of the composite outcome of death or initiation of mechanical circulatory support within 1 day of cardiac catheterization after adjustment for patient- and procedure-level factors.
RESULTS: A total of 6,339 procedures performed on 4,401 patients with a diagnosis of PH from 38 of 43 centers contributing data to the Pediatric Health Information Systems database were included. The observed risk of composite outcome was 3.5%. In multivariate modeling, the adjusted risk of the composite outcome was 3.3%. Younger age at catheterization, cardiac operation in the same admission as the catheterization, pre-procedural systemic vasodilator infusion, and hemodialysis were independently associated with an increased risk of adverse outcomes. Pre-procedural use of pulmonary vasodilators was associated with reduced risk of composite outcome.
CONCLUSIONS: The risk of cardiac catheterization in children and young adults with PH is high relative to previously reported risk in other pediatric populations. The risk is influenced by patient-level factors. Further research is necessary to determine whether knowledge of these factors can be translated into practices that improve outcomes for children with PH.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pediatric Health Information Systems Database; extracorporeal membrane oxygenation; intervention; mortality; outcomes research; pediatric cardiology

Mesh:

Year:  2015        PMID: 26361158      PMCID: PMC4567688          DOI: 10.1016/j.jacc.2015.07.032

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  30 in total

1.  Low weight as an independent risk factor for adverse events during cardiac catheterization of infants.

Authors:  Carl H Backes; Clifford Cua; Jacqueline Kreutzer; Laurie Armsby; Howaida El-Said; John W Moore; Kimberlee Gauvreau; Lisa Bergersen; Ralf J Holzer
Journal:  Catheter Cardiovasc Interv       Date:  2013-03-02       Impact factor: 2.692

2.  Quality metrics in cardiac catheterization for congenital heart disease: utility of 30-day mortality.

Authors:  Carl H Backes; Lisa Bergersen; Jonathan J Rome; Sarosh P Batlivala; Andrew C Glatz; Bugsu Ovunc; Sthuthi David; Brian K Rivera; Urbee Haque; Kevin Kollins; Han Yin; Ralf J Holzer
Journal:  Catheter Cardiovasc Interv       Date:  2014-10-07       Impact factor: 2.692

3.  Clinical features of paediatric pulmonary hypertension: a registry study.

Authors:  Rolf M F Berger; Maurice Beghetti; Tilman Humpl; Gary E Raskob; D Dunbar Ivy; Zhi-Cheng Jing; Damien Bonnet; Ingram Schulze-Neick; Robyn J Barst
Journal:  Lancet       Date:  2012-01-11       Impact factor: 79.321

4.  Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience.

Authors:  Kevin P Daly; Audrey C Marshall; Julie A Vincent; Warren A Zuckerman; Timothy M Hoffman; Charles E Canter; Elizabeth D Blume; Lisa Bergersen
Journal:  J Heart Lung Transplant       Date:  2011-12-30       Impact factor: 10.247

5.  Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry.

Authors:  Kevin D Hill; D Scott Lim; Allen D Everett; D Dunbar Ivy; J Donald Moore
Journal:  Catheter Cardiovasc Interv       Date:  2010-11-15       Impact factor: 2.692

6.  Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.

Authors:  Robyn J Barst; Michael D McGoon; C Gregory Elliott; Aimee J Foreman; Dave P Miller; D Dunbar Ivy
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

7.  Effect of center catheterization volume on risk of catastrophic adverse event after cardiac catheterization in children.

Authors:  Michael L O'Byrne; Andrew C Glatz; Russell T Shinohara; Natalie Jayaram; Matthew J Gillespie; Yoav Dori; Jonathan J Rome; Steven Kawut
Journal:  Am Heart J       Date:  2015-03-03       Impact factor: 4.749

8.  Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France.

Authors:  Alain Fraisse; Xavier Jais; Jean-Marc Schleich; Sylvie di Filippo; Pascale Maragnès; Maurice Beghetti; Virginie Gressin; Michel Voisin; Claire Dauphin; Pierre Clerson; François Godart; Damien Bonnet
Journal:  Arch Cardiovasc Dis       Date:  2010-02-11       Impact factor: 2.340

9.  Childhood idiopathic pulmonary arterial hypertension: a national cohort study.

Authors:  S Moledina; A A Hislop; H Foster; I Schulze-Neick; S G Haworth
Journal:  Heart       Date:  2010-04-20       Impact factor: 5.994

10.  Corticosteroids and outcome in children undergoing congenital heart surgery: analysis of the Pediatric Health Information Systems database.

Authors:  Sara K Pasquali; Matthew Hall; Jennifer S Li; Eric D Peterson; James Jaggers; Andrew J Lodge; Bradley S Marino; Denise M Goodman; Samir S Shah
Journal:  Circulation       Date:  2010-11-08       Impact factor: 29.690

View more
  23 in total

1.  Right Atrial Dilatation, Determined by Echocardiography, and Correlation with Right Atrial Pressure, Determined with Cardiac Catheterization, in Children with Pulmonary Hypertension.

Authors:  Georg Wucherer; Gernot Grangl; Stefan Kurath-Koller; Martin Koestenberger
Journal:  Pediatr Cardiol       Date:  2016-06-02       Impact factor: 1.655

2.  Right ventricular-vascular coupling ratio in pediatric pulmonary arterial hypertension: A comparison between cardiac magnetic resonance and right heart catheterization measurements.

Authors:  K T N Breeman; M Dufva; M J Ploegstra; V Kheyfets; T P Willems; J Wigger; K S Hunter; D D Ivy; R M F Berger; U Truong
Journal:  Int J Cardiol       Date:  2019-05-10       Impact factor: 4.164

3.  Association Between Variation in Preoperative Care Before Arterial Switch Operation and Outcomes in Patients With Transposition of the Great Arteries.

Authors:  Michael L O'Byrne; Andrew C Glatz; Lihai Song; Heather M Griffis; Marisa E Millenson; Matthew J Gillespie; Yoav Dori; Aaron G DeWitt; Christopher E Mascio; Jonathan J Rome
Journal:  Circulation       Date:  2018-11-06       Impact factor: 29.690

4.  Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database.

Authors:  Michael L O'Byrne; Russell T Shinohara; Elena K Grant; Joshua P Kanter; Matthew J Gillespie; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Am Heart J       Date:  2017-07-19       Impact factor: 4.749

5.  Prognostic Value of Change in Cardiac Index After Prostacyclin Initiation in Pediatric Pulmonary Hypertension.

Authors:  Patrick D Evers; Paul J Critser; Michelle Cash; Melissa Magness; Russel Hirsch
Journal:  Pediatr Cardiol       Date:  2020-09-24       Impact factor: 1.655

6.  Changes in Ventricular Geometry Predict Severity of Right Ventricular Hypertension.

Authors:  Konstantin Averin; Erik Michelfelder; Joshua Sticka; Michelle Cash; Russel Hirsch
Journal:  Pediatr Cardiol       Date:  2015-12-14       Impact factor: 1.655

7.  Trends in transcatheter and operative closure of patent ductus arteriosus in neonatal intensive care units: Analysis of data from the Pediatric Health Information Systems Database.

Authors:  Michael L O'Byrne; Marisa E Millenson; Connor B Grady; Jing Huang; Nicolas A Bamat; David A Munson; Lihai Song; Yoav Dori; Matthew J Gillespie; Jonathan J Rome; Andrew C Glatz
Journal:  Am Heart J       Date:  2019-08-17       Impact factor: 4.749

8.  Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces.

Authors:  Maria Jesus Del Cerro; Shahin Moledina; Sheila G Haworth; Dunbar Ivy; Maha Al Dabbagh; Hanaa Banjar; Gabriel Diaz; Alexandria Heath-Freudenthal; Ahmed Nasser Galal; Tilman Humpl; Snehal Kulkarni; Antonio Lopes; Ana Olga Mocumbi; G D Puri; Beyra Rossouw; S Harikrishnan; Anita Saxena; Patience Udo; Lina Caicedo; Omar Tamimi; Ian Adatia
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

9.  Trends in Discharge Prescription of Digoxin After Norwood Operation: An Analysis of Data from the Pediatric Health Information System (PHIS) Database.

Authors:  Michael L O'Byrne; Lihai Song; Jing Huang; David J Goldberg; Monique M Gardner; Chitra Ravishankar; Jonathan J Rome; Andrew C Glatz
Journal:  Pediatr Cardiol       Date:  2021-02-02       Impact factor: 1.655

10.  Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.

Authors:  Jun Yang; Melanie K Nies; Zongming Fu; Rachel Damico; Frederick K Korley; Paul M Hassoun; David D Ivy; Eric D Austin; Allen D Everett
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.